Back to Search
Start Over
PROFIT GROWTH SLOWS AT BIG DRUGMAKERS.
- Source :
-
Chemical & Engineering News . 8/22/2005, Vol. 83 Issue 34, p23-24. 2p. - Publication Year :
- 2005
-
Abstract
- Focuses on the slowdown in the second-quarter earnings in the core pharmaceutical businesses of big U.S. drug companies, due to patent expirations and product recalls. Better performance of European drug-makers compared to their U.S. counterparts; Comparison of the earnings of U.S. and European drug companies; Rise in the earnings of Wyeth Laboratories Inc. as well as Johnson & Johnson, while that of Pfizer and Merck & Co. Inc., plunged.
- Subjects :
- *PHARMACEUTICAL industry
*CORPORATE profits
*CORPORATE finance
*PROFIT
Subjects
Details
- Language :
- English
- ISSN :
- 00092347
- Volume :
- 83
- Issue :
- 34
- Database :
- Academic Search Index
- Journal :
- Chemical & Engineering News
- Publication Type :
- Periodical
- Accession number :
- 18115821
- Full Text :
- https://doi.org/10.1021/cen-v083n034.p023